Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 2761 results

Press release / Mar 23, 2026

Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026

New Rhapsido® REMIX-1 & -2 pooled analysis on symptom control as early as week 1 in chronic spontaneous urticaria (CSU) to be presentedLong-term Cosentyx® data build on extensive body of evidence…
Clinical Trials / Mar 20, 2026

Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
Clinical Trials / Mar 19, 2026

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
Clinical Trials / Mar 20, 2026

A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Clinical Trials / Mar 12, 2026

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Clinical Trials / Mar 05, 2026

Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea
Clinical Trials / Mar 05, 2026

Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)
Clinical Trials / Mar 09, 2026

A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
Clinical Trials / Feb 13, 2026

Remibrutinib in Real-world Clinical Practice - a US Sub-study
Clinical Trials / Mar 05, 2026

A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients